Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01714557
What this trial is testing

Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation

Who this might be right for
NeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 150
Large-scale testing (Phase 3)Looking for participantsNCT06294691
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Early research (Phase 1)Study completedNCT03383055
What this trial is testing

CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig

Who this might be right for
LymphomaMultiple Myeloma
Masonic Cancer Center, University of Minnesota 28
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Testing effectiveness (Phase 2)Study completedNCT02248597
What this trial is testing

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Who this might be right for
Graft Versus Host DiseaseHematopoietic/Lymphoid Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06931613
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaChildrenNivolumab+1 more
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Study completedNCT01883362
What this trial is testing

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT03532971
What this trial is testing

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

Who this might be right for
BK Virus Infection
Dana-Farber Cancer Institute 100
Testing effectiveness (Phase 2)Study completedNCT02572167
What this trial is testing

Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT06532084
What this trial is testing

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

Who this might be right for
Acute Myeloid Leukemia, in RelapseMyelodysplastic SyndromesChronic Myeloid Leukemia+1 more
St. Petersburg State Pavlov Medical University 88
Not applicableUnknownNCT04502628
What this trial is testing

Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

Who this might be right for
Stem Cell Transplant Complications
Shandong Provincial Hospital 150
Not applicableStudy completedNCT01930981
What this trial is testing

Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life

Who this might be right for
Hematologic MalignanciesOther Diagnoses, Comorbidities, and Complications
Fred Hutchinson Cancer Center 252
Testing effectiveness (Phase 2)UnknownNCT04622956
What this trial is testing

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

Who this might be right for
Graft Vs Host DiseaseHematopoietic Neoplasm
University of Sao Paulo General Hospital 47
Testing effectiveness (Phase 2)UnknownNCT05054465
What this trial is testing

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Israeli Medical Association 48
Testing effectiveness (Phase 2)Study completedNCT01058239
What this trial is testing

Bortezomib Plus Rituximab for EBV+ PTLD

Who this might be right for
Post-transplant Lymphoproliferative DiseaseSolid Organ TransplantStem Cell Transplant (Bone Marrow Transplant)+1 more
Massachusetts General Hospital 7
Not applicableLooking for participantsNCT06512519
What this trial is testing

Second Haplo-transplantation for Graft Failure

Who this might be right for
Graft FailureStem Cell Transplant Complications
Peking University People's Hospital 34
Not applicableNot Yet RecruitingNCT07140445
What this trial is testing

Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT

Who this might be right for
Stem Cell TransplantLate EffectNeurocognitive Dysfunction+3 more
Rigshospitalet, Denmark 175
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00032292
What this trial is testing

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Facet Biotech 34
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Next Page